ARL5B and breast cancer: Xu et al.’s work demonstrated the carcinogenic activity of FTO in promoting the invasion and migration of breast cancer cells via the FTO/miR-181b-3p/ARL5B signaling pathway, which highlighted the important role of FTO in tumor pathogenesis (37).